ClinicalTrials.Veeva

Menu
Principle Research Solutions, LLC | Spokane, WA logo

Principle Research Solutions, LLC | Spokane, WA

Research site

Site insights

Top conditions

Top treatments

Etrasimod
Dapsone
Crisaborole
BHV-3000
Ritlecitinib
PF-04965842
Ruxolitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Gregory Jared

Verified by this site

Active trials

2 of 7 total trials

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata (ALLEGRO-100)

The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. A...

Enrolling
Alopecia Areata
Drug: Placebo - 50 mg
Drug: Ritlecitinib 50 mg

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Trial sponsors

Pfizer logo
Incyte logo
McGill University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems